The characteristics of these molecular subtypes are largely distinguished by expression of various combinations of tumour markers such as oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2) and Ki67 tumour proliferation marker. The gene discussed is MKI67; the disease is neoplasm.